Skip to main content

Table 8 Comparison of changes in EQ-5D-5L scores from baseline to 26 weeks after treatment between patients who received Dangguixu-san and those who received placebo for acute lateral ankle sprain (n = 23 each)

From: Effects of Dangguixu-san in patients with acute lateral ankle sprain: a randomized controlled trial

Dependent variables Group(n) Week 0 (M ± SD) Week 27 (M ± SD) Difference (w27–w0) Z (p)a
Total EQ-5D-5L DS (n = 23) 10.48 ± 3.06 5.48 ± 1.04 − 5.00 ± 3.02 − 0.50 (0.618)
Placebo (n = 23) 10.17 ± 2.61 5.61 ± 1.27 − 4.57 ± 2.98
  1. aMann-Whitney U test